Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Findling

Showing results (251-260 of 443) with videos related to

Pageof 45
Sort By:
CNS Drugs|August 27, 2013
Comparative efficacy of guanfacine extended release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: applying matching-adjusted indirect comparison methodologyVanja Sikirica, Robert L Findling, James Signorovitch, et al.
The Journal of Clinical Psychiatry|March 4, 2008
A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorderRobert L Findling, Oscar G Bukstein, Raun D Melmed, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 23, 2003
An open-label pilot study of St. John's wort in juvenile depressionRobert L Findling, Nora K McNamara, Mary Ann O'Riordan, et al.
CNS Drugs|May 18, 2021
Viloxazine in the Management of CNS Disorders: A Historical Overview and Current StatusRobert L Findling, Shawn A Candler, Azmi F Nasser, et al.
Journal of Abnormal Child Psychology|August 15, 2014
Physical and sexual abuse and early-onset bipolar disorder in youths receiving outpatient services: frequent, but not specificTina Du Rocher Schudlich, Eric A Youngstrom, Maria Martinez, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|November 25, 2015
Adjunctive Maintenance Lamotrigine for Pediatric Bipolar I Disorder: A Placebo-Controlled, Randomized Withdrawal StudyRobert L Findling, Kiki Chang, Adelaide Robb, et al.
European Child & Adolescent Psychiatry|July 28, 2017
Assessing for suicidal behavior in youth using the Achenbach System of Empirically Based AssessmentAnna R Van Meter, Guillermo Perez Algorta, Eric A Youngstrom, et al.
JAACAP Open|November 18, 2024
Peer Review in <i>JAACAP Open</i>: Promoting Integrity While Advancing Open ScienceRobert R Althoff, Manpreet K Singh, Kara S Bagot, et al.
Pediatrics|December 2, 2009
Aripiprazole in the treatment of irritability in children and adolescents with autistic disorderRandall Owen, Linmarie Sikich, Ronald N Marcus, et al.
Journal of Attention Disorders|March 30, 2019
A Phase II Double-Blind, Placebo-Controlled, Efficacy and Safety Study of SPN-812 (Extended-Release Viloxazine) in Children With ADHDJanet K Johnson, Tesfaye Liranso, Keith Saylor, et al.
Pageof 45

Showing results (251-260 of 443) with videos related to

Sort By:
Pageof 45
CNS Drugs|August 27, 2013
Comparative efficacy of guanfacine extended release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: applying matching-adjusted indirect comparison methodologyVanja Sikirica, Robert L Findling, James Signorovitch, et al.
The Journal of Clinical Psychiatry|March 4, 2008
A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorderRobert L Findling, Oscar G Bukstein, Raun D Melmed, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 23, 2003
An open-label pilot study of St. John's wort in juvenile depressionRobert L Findling, Nora K McNamara, Mary Ann O'Riordan, et al.
CNS Drugs|May 18, 2021
Viloxazine in the Management of CNS Disorders: A Historical Overview and Current StatusRobert L Findling, Shawn A Candler, Azmi F Nasser, et al.
Journal of Abnormal Child Psychology|August 15, 2014
Physical and sexual abuse and early-onset bipolar disorder in youths receiving outpatient services: frequent, but not specificTina Du Rocher Schudlich, Eric A Youngstrom, Maria Martinez, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|November 25, 2015
Adjunctive Maintenance Lamotrigine for Pediatric Bipolar I Disorder: A Placebo-Controlled, Randomized Withdrawal StudyRobert L Findling, Kiki Chang, Adelaide Robb, et al.
European Child & Adolescent Psychiatry|July 28, 2017
Assessing for suicidal behavior in youth using the Achenbach System of Empirically Based AssessmentAnna R Van Meter, Guillermo Perez Algorta, Eric A Youngstrom, et al.
JAACAP Open|November 18, 2024
Peer Review in <i>JAACAP Open</i>: Promoting Integrity While Advancing Open ScienceRobert R Althoff, Manpreet K Singh, Kara S Bagot, et al.
Pediatrics|December 2, 2009
Aripiprazole in the treatment of irritability in children and adolescents with autistic disorderRandall Owen, Linmarie Sikich, Ronald N Marcus, et al.
Journal of Attention Disorders|March 30, 2019
A Phase II Double-Blind, Placebo-Controlled, Efficacy and Safety Study of SPN-812 (Extended-Release Viloxazine) in Children With ADHDJanet K Johnson, Tesfaye Liranso, Keith Saylor, et al.
Pageof 45